BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20649476)

  • 21. Therapeutic and Mechanistic Effects of Curcumin in Huntington's Disease.
    Labanca F; Ullah H; Khan H; Milella L; Xiao J; Dajic-Stevanovic Z; Jeandet P
    Curr Neuropharmacol; 2021; 19(7):1007-1018. PubMed ID: 32442088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of iPSC lines from archived non-cryoprotected biobanked dura mater.
    Sproul AA; Vensand LB; Dusenberry CR; Jacob S; Vonsattel JP; Paull DJ; Shelanski ML; Crary JF; Noggle SA
    Acta Neuropathol Commun; 2014 Jan; 2():4. PubMed ID: 24398250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomics: An Emerging "Omics" Platform for Systems Biology and Its Implications for Huntington Disease Research.
    Akyol S; Ashrafi N; Yilmaz A; Turkoglu O; Graham SF
    Metabolites; 2023 Dec; 13(12):. PubMed ID: 38132886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation of the MUSIe002-A human embryonic stem cell line.
    Khampang S; Laowtammathron C; Lorthongpanich C; Klaihmon P; Chingsuwanrote P; Choavaratana R; Phornwilardsiri S; Sitthirit K; Srisook P; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2022 Mar; 59():102660. PubMed ID: 35033856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome.
    Gridina MM; Shitik EM; Lemskaya NA; Minina JM; Grishchenko IV; Dolskiy AA; Shorina AR; Maksimova YV; Yudkin DV
    Stem Cell Res; 2021 Dec; 57():102615. PubMed ID: 34864218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.
    HD iPSC Consortium
    Cell Stem Cell; 2012 Aug; 11(2):264-78. PubMed ID: 22748968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardization of Cell Culture Conditions and Routine Genomic Screening under a Quality Management System Leads to Reduced Genomic Instability in hPSCs.
    Molina-Ruiz FJ; Introna C; Bombau G; Galofre M; Canals JM
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.
    Akimov SS; Jiang M; Kedaigle AJ; Arbez N; Marque LO; Eddings CR; Ranum PT; Whelan E; Tang A; Wang R; DeVine LR; Talbot CC; Cole RN; Ratovitski T; Davidson BL; Fraenkel E; Ross CA
    Hum Mol Genet; 2021 Nov; 30(24):2469-2487. PubMed ID: 34296279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review.
    Monk R; Connor B
    Cells; 2021 Jun; 10(7):. PubMed ID: 34206228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.
    Latoszek E; Czeredys M
    Front Cell Dev Biol; 2021; 9():657337. PubMed ID: 33869222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
    Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
    Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.
    Zeitler B; Froelich S; Marlen K; Shivak DA; Yu Q; Li D; Pearl JR; Miller JC; Zhang L; Paschon DE; Hinkley SJ; Ankoudinova I; Lam S; Guschin D; Kopan L; Cherone JM; Nguyen HB; Qiao G; Ataei Y; Mendel MC; Amora R; Surosky R; Laganiere J; Vu BJ; Narayanan A; Sedaghat Y; Tillack K; Thiede C; Gärtner A; Kwak S; Bard J; Mrzljak L; Park L; Heikkinen T; Lehtimäki KK; Svedberg MM; Häggkvist J; Tari L; Tóth M; Varrone A; Halldin C; Kudwa AE; Ramboz S; Day M; Kondapalli J; Surmeier DJ; Urnov FD; Gregory PD; Rebar EJ; Muñoz-Sanjuán I; Zhang HS
    Nat Med; 2019 Jul; 25(7):1131-1142. PubMed ID: 31263285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human ESC-Derived Chimeric Mouse Models of Huntington's Disease Reveal Cell-Intrinsic Defects in Glial Progenitor Cell Differentiation.
    Osipovitch M; Asenjo Martinez A; Mariani JN; Cornwell A; Dhaliwal S; Zou L; Chandler-Militello D; Wang S; Li X; Benraiss SJ; Agate R; Lampp A; Benraiss A; Windrem MS; Goldman SA
    Cell Stem Cell; 2019 Jan; 24(1):107-122.e7. PubMed ID: 30554964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases.
    Kumar S; Karthikeyan N; Mishra S; Padmanabhan P; Radda G; Gulyás B
    Mol Neurobiol; 2019 Apr; 56(4):2559-2578. PubMed ID: 30043261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.
    Wiatr K; Szlachcic WJ; Trzeciak M; Figlerowicz M; Figiel M
    Mol Neurobiol; 2018 Apr; 55(4):3351-3371. PubMed ID: 28497201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.
    Tousley A; Kegel-Gleason KB
    J Huntingtons Dis; 2016 Jun; 5(2):99-131. PubMed ID: 27372054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.
    Benraiss A; Wang S; Herrlinger S; Li X; Chandler-Militello D; Mauceri J; Burm HB; Toner M; Osipovitch M; Jim Xu Q; Ding F; Wang F; Kang N; Kang J; Curtin PC; Brunner D; Windrem MS; Munoz-Sanjuan I; Nedergaard M; Goldman SA
    Nat Commun; 2016 Jun; 7():11758. PubMed ID: 27273432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant-Negative Effects of Adult-Onset Huntingtin Mutations Alter the Division of Human Embryonic Stem Cells-Derived Neural Cells.
    Lopes C; Aubert S; Bourgois-Rocha F; Barnat M; Rego AC; Déglon N; Perrier AL; Humbert S
    PLoS One; 2016; 11(2):e0148680. PubMed ID: 26863614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating Cell Processes, Quality, and Biomarkers in Pluripotent Stem Cells Using Video Bioinformatics.
    Zahedi A; On V; Lin SC; Bays BC; Omaiye E; Bhanu B; Talbot P
    PLoS One; 2016; 11(2):e0148642. PubMed ID: 26848582
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.